Literature DB >> 19786959

Structural changes of fovea during remission of Behçet's disease as imaged by spectral domain optical coherence tomography.

N Unoki1, K Nishijima, M Kita, R Hayashi, N Yoshimura.   

Abstract

PURPOSE: To acquire the image of the fovea during remission of ocular Behçet's disease using spectral domain optical coherence tomography (SD-OCT) and to further assess the correlation between best-corrected visual acuity (BCVA) and SD-OCT findings.
METHODS: A total of 24 eyes of 14 patients with ocular Behçet's disease were examined with SD-OCT. The relationships between BCVA and other clinical characteristics, including foveal thickness and status of external limiting membrane (ELM) or the junction between photoreceptor inner and outer segments (IS/OS), were analysed for statistical significance.
RESULTS: BCVA in eyes with intact IS/OS was significantly better than that in eyes with ill-defined IS/OS (P=0.0001). Foveal thickness (P=0.0001) and male sex (P=0.03) were also significantly different between eyes with and without complete IS/OS line.
CONCLUSIONS: Definition of the IS/OS line by SD-OCT, but not status of the ELM line, appears to be associated with BCVA in patients with ocular Behçet's disease. Accordingly, SD-OCT may prove useful in the evaluation of visual function after ocular attacks of Behçet's disease.

Entities:  

Mesh:

Year:  2009        PMID: 19786959     DOI: 10.1038/eye.2009.231

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  10 in total

Review 1.  Optical coherence tomography imaging in uveitis.

Authors:  Sumru Onal; Ilknur Tugal-Tutkun; Piergiorgio Neri; Carl P Herbort
Journal:  Int Ophthalmol       Date:  2013-07-09       Impact factor: 2.031

2.  Morphometric spectral-domain optical coherence tomography features of epiretinal membrane correlate with visual acuity in patients with uveitis.

Authors:  Hossein Nazari; Laurie Dustin; Florian M Heussen; Srinivas Sadda; Narsing A Rao
Journal:  Am J Ophthalmol       Date:  2012-04-26       Impact factor: 5.258

3.  Correlation between Ocular Manifestations and Their Complications as Opposed to Visual Acuity and Treatment in Behcet's Disease.

Authors:  Jelena Paovic; Predrag Paovic; Vojislav Sredovic
Journal:  Autoimmune Dis       Date:  2013-08-29

4.  Evaluation of the Macular, Peripapillary Nerve Fiber Layer and Choroid Thickness Changes in Behçet's Disease with Spectral-Domain OCT.

Authors:  Mustafa Ataş; Isa Yuvacı; Süleyman Demircan; Emel Güler; Orhan Altunel; Emine Pangal; Altan Göktaş; Serap Sütbeyaz; Gökmen Zararsız
Journal:  J Ophthalmol       Date:  2014-04-24       Impact factor: 1.909

Review 5.  Photoreceptor inner segment ellipsoid band integrity on spectral domain optical coherence tomography.

Authors:  Sandeep Saxena; Khushboo Srivastav; Chui M Cheung; Joanne Yw Ng; Timothy Yy Lai
Journal:  Clin Ophthalmol       Date:  2014-12-09

6.  Choroidal thickness in non-ocular Behçet's disease - A spectral-domain OCT study.

Authors:  Aman Mittal; Swetha Bindu Velaga; Khalil Ghasemi Falavarjani; Muneeswar G Nittala; Srinivas R Sadda
Journal:  J Curr Ophthalmol       Date:  2017-06-26

7.  Epiretinal membrane profile on spectral domain optical coherence tomography in patients with uveitis.

Authors:  Puja Maitra; Dhivya Ashok Kumar; Amar Agarwal
Journal:  Indian J Ophthalmol       Date:  2019-03       Impact factor: 1.848

8.  Retinal microvasculature features in patients with Behcet's disease: a systematic review and meta-analysis.

Authors:  Kai-Bao Ji; Zhe Hu; Qing-Lin Zhang; Hai-Feng Mei; Yi-Qiao Xing
Journal:  Sci Rep       Date:  2022-01-14       Impact factor: 4.379

9.  Epiretinal membranes in patients with uveitis: morphological and functional analysis with spectral domain optical coherence tomography.

Authors:  Ludovico Iannetti; Paolo Tortorella; Enzo D'Ambrosio; Rossela Spena; Roberta Zito; Magda Gharbiya
Journal:  Biomed Res Int       Date:  2013-11-05       Impact factor: 3.411

10.  Reconstitution of disrupted photoreceptor layer in uveitis associated with Behçet's disease by infliximab treatment.

Authors:  Masaru Takeuchi; Kozo Harimoto; Manzo Taguchi; Yutaka Sakurai
Journal:  BMC Ophthalmol       Date:  2015-12-12       Impact factor: 2.209

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.